ArticleInternational immunopharmacology2022

Comparing efficacy and safety of tocilizumab and methylprednisolone in the treatment of patients with severe COVID-19.

Ladan Abbasian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.